Long-acting progestogen contraceptives
Power, J.; Guillebaud, J.
Practitioner 246(1634): 332; 335-341
2002
ISSN/ISBN: 0032-6518 PMID: 12043350 Document Number: 542355
Document emailed within 1 workday
Related Documents
Li, X.F.; Davies, G.C.; Newton, J. 1992: A review of the effects of long-acting progestogen-only contraceptives on ovarian activity Advances in Contraception: the Official Journal of the Society for the Advancement of Contraception 8(1): 1-19Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495
Plesner, R. 1969: Contraception by an injectable, long-acting oestrogen-progestogen agent Acta Endocrinologica 61(3): 494-508
Kesserü-Koós, E.; Larrañaga-Legufa, A.; Hurtado-Koo, H.; Scharff, H.J. 1973: Fertility control with norethindrone enanthate, a long-acting parenteral progestogen Acta Europaea Fertilitatis 4(4): 203-221
Kesserü-Koós, E.; Larrañaga-Legufa, A.; Hurtado-Koo, H.; Scharff, H.J. 1973: Fertility control with norethindrone enanthate, a long-acting parenteral progestogen Acta Europaea Fertilitatis 4(4): 203-221
Ferreira, J.és.M.; Nunes, F.R.; Modesto, W.; Gonçalves, M.P.; Bahamondes, L. 2014: Reasons for Brazilian women to switch from different contraceptives to long-acting reversible contraceptives Contraception 89(1): 17-21
Ferreira, J.és.M.; Nunes, F.R.; Modesto, W.; Gonçalves, M.P.; Bahamondes, L. 2014: Reasons for Brazilian women to switch from different contraceptives to long-acting reversible contraceptives Contraception 89(1): 17-21
Ferreira, J.és.M.; Nunes, F.R.; Modesto, W.; Gonçalves, M.P.; Bahamondes, L. 2014: Reasons for Brazilian women to switch from different contraceptives to long-acting reversible contraceptives Contraception 89(1): 17-21
Dale, E.; Spivey, S.H. 1971: Serum proteins of women utilizing combination oral contraceptives or long acting injectable progestational contraceptives Contraception 4(4): 241-251
Dale, E.; Spivey, S.H. 1971: Serum proteins of women utilizing combination oral contraceptives or long acting injectable progestational contraceptives Contraception 4(4): 241-251
Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Asnake, M.; Henry, E.G.; Tilahun, Y.; Oliveras, E. 2013: Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 123 Suppl. 1: E29-E32
Asnake, M.; Henry, E.G.; Tilahun, Y.; Oliveras, E. 2013: Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 123 Suppl. 1: E29-E32
Asnake, M.; Henry, E.G.; Tilahun, Y.; Oliveras, E. 2013: Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 123 Suppl. 1: E29-E32
Benagiano, G.; Primiero, F.M. 1983: Long acting contraceptives. Present status Drugs 25(6): 570-609
A.Med Assoc Board Trustees 1992: Requirements or incentives by government for the use of long acting contraceptives Journal of the American Medical Association 267(13): 1818-1821